// App-Quantinova.ai

: Venetoclax Enhances the Efficacy of Therapeutic Antibodies in B-Cell Malignancies

Researchers

Presenter

  • Fotini Vogiatzi

Principal Investigators

  • Julia Heymann

  • Thies Rsner

  • Lennart Lenk

  • Gunnar Cario

  • Martin Schrappe

  • Beat Bornhauser

  • Jean-Pierre Bourquin

  • Simon Bomken

  • Thomas Valerius

  • Matthias Peipp

  • Christian Kellner

  • Denis Martin Schewe

Medical Centers

  • Department of Pediatrics I, Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

  • Division of Stem Cell Transplantation and Immunotherapy, nd Department of Medicine, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany

  • Department of Oncology and Childrens Research Center, University Childrens Hospital, Zurich, Switzerland

  • Department of Oncology, Division of Pediatric Oncology, and Children Research Center, University Children´s Hospital Zurich, Zurich, Switzerland

  • Pediatric Oncology Department, Pediatric Oncology, Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, United Kingdom

  • Division of Transfusion Medicine, Cell Therapeutics and Hemostaseology, Department of Anesthesiology, Ludwig-Maximilians University Munich, Munich, Germany

Locations

  • Germany

  • Switzerland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • B-Cell Non-Hodgkin Lymphoma

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • B cell lymphomas

  • Burkitt lymphoma

  • Hodgkin's Lymphoma

  • Lymphomas

Biomarkers

  • B-cell lymphoma 2

Drug/Treatment

  • daratumumab Intravenous

  • Venetoclax

  • Rituximab

  • Tafasitamab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved